Cargando…

Antioxidant effect of isoflavones: A randomized, double-blind, placebo controlled study in oophorectomized women

BACKGROUND: One of the postulated mechanism for cardioprotective potential of isoflavones is their ability to exert antioxidant action. However, various reports give conflicting results in this area. AIM: The present study was conducted with an objective to probe into the cardioprotective mechanism...

Descripción completa

Detalles Bibliográficos
Autores principales: Mittal, Rakesh, Mittal, Niti, Hota, Debasish, Suri, Vanita, Aggarwal, Neelam, Chakrabarti, Amitava
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3931210/
https://www.ncbi.nlm.nih.gov/pubmed/24600575
http://dx.doi.org/10.4103/2229-516X.125686
Descripción
Sumario:BACKGROUND: One of the postulated mechanism for cardioprotective potential of isoflavones is their ability to exert antioxidant action. However, various reports give conflicting results in this area. AIM: The present study was conducted with an objective to probe into the cardioprotective mechanism of isoflavones by evaluating their antioxidant potential in oophorectomized women. MATERIALS AND METHODS: This was a randomized, double-blind, parallel, placebo controlled study. A total of 43 women were randomized to receive 75 mg/day isoflavones tablet or placebo for 12 weeks. Red blood cell antioxidant parameters including lipid peroxidation, superoxide dismutase (SOD), catalase and glutathione peroxidase (GSH-Px) were determined at baseline and at the end of the study. RESULTS: After 12 weeks of administration of isoflavones, there was no statistically significant difference in lipid peroxidation (P value for isoflavones: 0.37; for placebo: 0.37), catalase (P value for isoflavones: 0.35; for placebo: 0.84), SOD (P value for isoflavones: 0.41; for placebo: 0.28) and GSH-Px (P value for isoflavones: 0.92; for placebo: 0.29). There was no statistically significant difference in the proportion of patients experiencing adverse events in the two groups (P -1.00). CONCLUSION: The study strengthens the concept that the cardioprotective mechanism of isoflavones might be due to some other reason apart from the antioxidant pathway.